Table 1.
Characteristic | Value (IQR) for the parameter |
---|---|
Gender (%) | |
Female | 65 |
Male | 35 |
Median age at sampling (yr) | 27 (25–34) |
Fiebig stage at sampling (% patients) | |
Stage IV | 8.3 |
Stage V | 75 |
Stage VI | 11.7 |
Unknown | 5 |
Median viral load at sampling (log10copies/ml) | 5.06 (4.33–5.57) |
Median CD4 count at sampling (cells/mm3) | 418 (302–524) |
Median viral load set point (log10copies/ml) | 4.69 (4.11–5.15) |
Median rate of CD4 decline (cells/mm3 per month) | −7 (−13 to 1) |
Median follow-up time (days) | 365 (184–457) |